Henry Schein, Inc. (HSIC) compared with its closest peers (XRAY, NVST, ACH, BAX, MDLN): P/E 25.1 vs industry 23.9. Peer set by Wholesale; 10 comparable wholesalers. First-party data.
DENTSPLY SIRONA and Envista: named a competitor in the 10-K; Accendra Health shares Henry Schein's sub-industry, medical equipment wholesalers.
| Company | Market Cap | P/E |
|---|---|---|
| DENTSPLY SIRONA Inc. (XRAY) | $2.29B | -3.8 |
| Envista Holdings Corp (NVST) | $4.43B | 46.7 |
| Accendra Health, Inc. (ACH) | $93.82M | -0.6 |
| Baxter International Inc. (BAX) | $13.22B | -10.2 |
| Medline Inc. (MDLN) | $31.52B | 30.7 |
| Intuitive Surgical, Inc. (ISRG) | $130.68B | 41.6 |
| GE HealthCare Technologies Inc. (GEHC) | $31.71B | 16.6 |
| Boston Scientific Corporation (BSX) | $68.03B | 18.5 |
| Zimmer Biomet Holdings, Inc. (ZBH) | $19.13B | 25.1 |
| Becton, Dickinson and Company (BDX) | $51.09B | 54.3 |
| Stock P/E | 25.1 |
| Sector P/E (Consumer Discretionary) | 20.2 |
| Industry P/E (Wholesale) | 23.9 |
| vs Sector | 24.6% |
| vs Industry | 5.3% |
HSIC overview · HSIC earnings · HSIC financials · HSIC KPIs · HSIC documents · HSIC ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.